JC, Berking C, Postow MA, Bisschop K, Simeone E, Mangana J, Schilling B, Di Giacomo AM, Brenner N, Kähler K, Heinzerling L, Gutzmer R, Bender A, Gebhardt C, Romano E, Meier F, Martus P, Maio M, Blank C, Schadendorf D, Dummer R, Ascierto PA, Hospers G, Garbe C, Wolchok JD. Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab. Clin Cancer Res. 2016 Nov 15;22(22):5487-5496. \[[PMC free article: PMC5572569](/pmc/articles/PMC5572569/)\] \[[PubMed: 27185375](https://pubmed.ncbi.nlm.nih.gov/27185375)\] 34. Bedikian AY, Millward M, Pehamberger H, Conry R, Gore M, Trefzer U, Pavlick AC, DeConti R, Hersh EM, Hersey P, Kirkwood JM, Haluska FG., Oblimersen Melanoma Study Group. Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group. J Clin Oncol. 2006 Oct 10;24(29):4738-45. \[[PubMed: 16966688](https://pubmed.ncbi.nlm.nih.gov/16966688)\] 35. Smylie MG. Use of immuno-oncology in melanoma. Curr Oncol. 2020 Apr;27(Suppl 2):S51-S58. \[[PMC free article: PMC7194004](/pmc/articles/PMC7194004/)\] \[[PubMed: 32368174](https://pubmed.ncbi.nlm.nih.gov/32368174)\] 36. Yao Y, Wang H, Li B. LDH5 overexpression is associated with poor survival in patients with solid tumors: a meta-analysis. Tumour Biol. 2014 Jul;35(7):6973-81. \[[PubMed: 24744144](https://pubmed.ncbi.nlm.nih.gov/24744144)\] 37. Monroe GR, van Eerde AM, Tessadori F, Duran KJ, Savelberg SMC, van Alfen JC, Terhal PA, van der Crabben SN, Lichtenbelt KD, Fuchs SA, Gerrits J, van Roosmalen MJ, van Gassen KL, van Aalderen M, Koot BG, Oostendorp M, Duran M, Visser G, de Koning TJ, Calì F, Bosco P, Geleijns K, de Sain-van der Velden MGM, Knoers NV, Bakkers J, Verhoeven-Duif NM, van Haaften G, Jans JJ. Identification of human D lactate dehydrogenase deficiency. Nat Commun. 2019 Apr 01;10(1):1477. \[[PMC free article: PMC6443703](/pmc/articles/PMC6443703/)\] \[[PubMed: 30931947](https://pubmed.ncbi.nlm.nih.gov/30931947)\] 38. Lee BJ, Zand L, Manek NJ, Hsiao LL, Babovic-Vuksanovic D, Wylam ME, Qian Q. Physical therapy-induced rhabdomyolysis and acute kidney injury associated with reduced activity of muscle lactate dehydrogenase A. Arthritis Care Res (Hoboken). 2011 Dec;63(12):1782-6. \[[PubMed: 22127970](https://pubmed.ncbi.nlm.nih.gov/22127970)\] 39. Lund AM, Christensen E, Skovby F. [Diagnosis and acute treatment of inborn metabolic diseases in infants]. Ugeskr Laeger. 2002 Nov 25;164(48):5613-9. \[[PubMed: 12523004](https://pubmed.ncbi.nlm.nih.gov/12523004)\] 40. Walenta S, Mueller-Klieser WF. Lactate: mirror and motor of tumor malignancy. Semin Radiat Oncol. 2004 Jul;14(3):267-74. \[[PubMed: 15254870](https://pubmed.ncbi.nlm.nih.gov/15254870)\] 41. Rojas-Pirela M, Andrade-Alviárez D, Rojas V, Marcos M, Salete-Granado D, Chacón-Arnaude M, Pérez-Nieto MÁ, Kemmerling U, Concepción JL, Michels PAM, Quiñones W. Exploring glycolytic enzymes in disease: potential biomarkers and therapeutic targets in neurodegeneration, cancer and parasitic infections. Open Biol. 2025 Feb;15(2):240239. \[[PMC free article: PMC11793985](/pmc/articles/PMC11793985/)\] \[[PubMed: 39904372](https://pubmed.ncbi.nlm.nih.gov/39904372)\] 42. Fang T, Hu L, Chen T, Li F, Yang L,